Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.
Press releases published on August 12, 2025
Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
August 12, 2025
- Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 - - Completed enrollment of Phase 2 MoonStone trial in Relapsing Multiple Sclerosis; results expected early in the fourth quarter 2025 - …
Gilat Receives a Multimillion Contract from Israel’s Ministry of Defense for Advanced Strategic Defense SATCOM Project
GlobeNewswire
·
August 12, 2025
PETAH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that its defense division, Gilat Defense, has …
Lithium Argentina and Ganfeng to Form New Joint Venture to Consolidate the Pozuelos and Pastos Grandes Basins
GlobeNewswire
·
August 12, 2025
ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Lithium Argentina AG. (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) is pleased to announce the execution of a framework agreement (the “Framework Agreement”) with Ganfeng Lithium Group Co. …
Greenland Lithium Pegmatite Field Significantly Expanded by Brunswick Exploration
GlobeNewswire
·
August 12, 2025
MONTREAL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; “BRW” or the “Company”) is pleased to announced that it has identified the country’s largest spodumene pegmatite trend. The discovery of …
Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
August 12, 2025
Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Expect decision to advance an oligomer-targeted Enhanced Brain DeliveryTM product candidate in …
Trident Resources Announces the Acquisition of Claims from Eagle Plains Resources Within the La Ronge Gold Belt in Saskatchewan, Canada
GlobeNewswire
·
August 12, 2025
Vancouver, BC, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce that it has signed a non-arm’s length agreement (the “Agreement”) with Eagle Plains Resources Ltd. …
Ocular Therapeutix™ Receives FDA Agreement Under Special Protocol Assessment (SPA) for Registrational Trial of AXPAXLI™ in NPDR
GlobeNewswire
·
August 12, 2025
BEDFORD, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced it has received written agreement regarding a …
Discovery Reports 50,552 Ounces of Gold Production, $27.3 Million of Free Cash Flow¹ in Q2 2025
GlobeNewswire
·
August 12, 2025
TRANSFORMATIONAL QUARTER Acquired Porcupine Complex on April 15th, establishes Discovery as growing Canadian gold producer Finalized $575.0 million financing package, including $475.0M of royalty …
Altimmune Announces Second Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
August 12, 2025
Positive data from the IMPACT Phase 2b trial reinforces the potential for pemvidutide to be a highly differentiated MASH therapy Pemvidutide is the first product candidate to achieve statistically significant MASH resolution and weight loss at 24 weeks New …
Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress
GlobeNewswire
·
August 12, 2025
--Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal side effects compared to semaglutide alone-- --Company …
Titan Mining Delivers Strong Q2 Results; On Track to Commission First Integrated U.S. Graphite Facility in 2025
GlobeNewswire
·
August 12, 2025
GOUVERNEUR, N.Y. and VANCOUVER, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Titan Mining Corporation (TSX: TI; OTCQB: TIMCF) ("Titan" or the "Company") today announced its financial and operating results for the quarter ended June 30, 2025. The …
AIStorm & Tower Semiconductor Introduce Cheetah HS, World’s First Up-to-260K FPS AI-in-Imager Chip for Inspection, Robotics & Sports
GlobeNewswire
·
August 12, 2025
Charge-domain imager with on-chip neural network, provides breakthrough slow-motion vision at a fraction of the cost and power consumption of competing high-speed cameras HOUSTON, Texas, and MIGDAL HAEMEK, Israel - August 12, 2025: AIStorm, the market …
tpay Releases White Paper on Unlocking Business Opportunities With New Digital Payments
GlobeNewswire
·
August 12, 2025
DUBAI, United Arab Emiates, Aug. 12, 2025 (GLOBE NEWSWIRE) -- tpay, the leading payment connector in the META region, has published a new white paper exploring the rapidly evolving payments landscape, highlighting the forces reshaping how we pay and why it …
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
GlobeNewswire
·
August 12, 2025
ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs, …
Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies
GlobeNewswire
·
August 12, 2025
VANCOUVER, British Columbia and RIYADH, Saudi Arabia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through artificial …
Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering
GlobeNewswire
·
August 12, 2025
JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $400.0 million aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private …
Prime Mining Reports Q2 2025 Financial and Operating Results
GlobeNewswire
·
August 12, 2025
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) is pleased to report its operating and financial results for the quarter ended June 30, 2025. Prime is …